The tail of what's possible with ML is very long. We've just only picked the low-hanging fruit. Medtech is going to be big this century, as biocompatible nanot

The tail of what's possible with ML is very long. We've just only picked the low-hanging fruit. Medtech is going to be big this century, as biocompatible nanotech and the shockwaves of CRISPR reverberate through industry over the next couple decades. Not saying immortality is coming or anything, but within 20-30 years we'll probably see a slew of new therapies and products. And if anyone figures out a really good, affordable BCI, then that's another Pandora's box of possibilities. Also, I respectfully disagree on a downward trend of ad revenue. The rise of advertorials in news outlets, product-placement-driven subscription media a la Netflix, and the whole influencer thing indicates our future will be even more fully integrated with advertisement. The per-impression cost may still fall, but look forward to the day when anyone with friends is micro-compensated in realtime for mentioning Coke at a party.